Recent data showed that the Adenosine 2a Receptor (A2aR) is a component of the negative feedback loop for T cell activation that is upregulated during T cell activation, and blockade of A2aR has been shown to increase the efficacy of tumor vaccines in pre-clinical models [46]. Here, ADORA2A is linked to neoplasm.